EichorEICHOR
Location: Merksem Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Merksem

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · ZNA Jan Palfijn · Hoffmann-La Roche · NCT07284121Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · ZNA Jan Palfijn · Eli Lilly and Company · NCT07353931Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With
Phase 4 · ZNA Jan Palfijn · Universitaire Ziekenhuizen KU Leuven · NCT06003283Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Phase 1 · Research Site · AstraZeneca · NCT07201558A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standa
Phase 3 · Research Site · AstraZeneca · NCT06455449CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS
Phase 4 · ZAS Paflijn · University Hospital, Antwerp · NCT07189091Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3 · Ziekenhuis Netwerk Antwerpen Jan Palfijn · Amgen · NCT04804553
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.